Véronique Secq

2.7k citations
41 papers · 1.1k indexed · h-index 15
Topics
Myasthenia Gravis and Thymoma (7 papers)HER2/EGFR in Cancer Research (5 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers)

In The Last Decade

Véronique Secq

40 papers receiving 1.1k citations

Peers

Véronique Secq
Comparison fields: 5 of 88
  • Molecular Biology 448
  • Oncology 431
  • Immunology 278
  • Cancer Research 251
  • Pulmonary and Respiratory Medicine 177
Replace Ryo Nagashio with:
Ryo Nagashio Japan
Jason E. Toombs United States
Tingguo Zhang China
Roger Mouawad France
Xuhui Bao United States
Karin Wadt Denmark
Michela Croce Italy
Koushiro Ohtsubo Japan
Michiko Harao Japan
Véronique Secq relative to Ryo Nagashio Japan Ryo Nagashio's profile →
Citations per field
00.5×1.5×1.8×
Ryo Nagashio · 1×
Citations per year

Countries citing papers authored by Véronique Secq

Since Specialization
Citations

This map shows the geographic impact of Véronique Secq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Secq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Secq more than expected).

Fields of papers citing papers by Véronique Secq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Secq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Secq. The network helps show where Véronique Secq may publish in the future.

Co-authorship network of co-authors of Véronique Secq

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Secq. A scholar is included among the top collaborators of Véronique Secq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Secq. Véronique Secq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 9
3 43
4 32
5 82
6 13
7 2
8 4
9 12
10 3
11 12
12 35
13 5
14 11
15 1
16 26
17 63
18 27
19 17
20 47

About Véronique Secq

Véronique Secq is a scholar working on Microbiology, Neurology and Oncology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (7 papers), HER2/EGFR in Cancer Research (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). The work is most often cited by research in Cancer Research (251 citations), Oncology (431 citations) and Immunology (278 citations). Véronique Secq has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Juan Iovanna, Stéphane Garcia, Marie‐Noëlle Lavaut, Richard Tomasini, Sophie Vasseur, Sophie Lac, Julie Roques, Fabienne Guillaumond, Marion Rubis and Colette Charpin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026